Summary

Persistence Market Research has recently released a comprehensive report on the worldwide market for influenza diagnostics. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Influenza Diagnostics Market Size (2024E): USD 1.8 Billion
• Projected Market Value (2033F): USD 3.0 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 6.1%

Influenza Diagnostics Market - Report Scope:

Influenza diagnostics play a crucial role in the early detection, treatment, and management of influenza infections. These diagnostics include rapid influenza diagnostic tests (RIDTs), reverse transcription-polymerase chain reaction (RT-PCR) assays, and other molecular diagnostic tools. The market serves hospitals, clinics, diagnostic laboratories, and homecare settings, offering a range of diagnostic devices that provide timely and accurate results to manage influenza outbreaks effectively. Market growth is driven by the increasing prevalence of influenza, rising healthcare expenditures, and advancements in diagnostic technology, which enhance detection accuracy and reduce diagnostic time.

Market Growth Drivers:

The global influenza diagnostics market is propelled by several key factors, including growing awareness about early diagnosis and treatment of influenza to prevent complications and transmission. The rising incidence of influenza infections, coupled with the demand for effective diagnostic solutions during seasonal outbreaks, further drives market expansion. Technological advancements, such as the development of highly sensitive and specific molecular diagnostic tools, offer improved detection rates and shorter turnaround times, fostering market growth. Moreover, the increasing adoption of point-of-care testing and home-based diagnostic solutions creates new avenues for market players to reach a wider patient population.

Market Restraints:

Despite promising growth prospects, the influenza diagnostics market faces challenges related to regulatory compliance, reimbursement policies, and competition from alternative diagnostic methods. Stringent regulations governing the manufacturing, marketing, and use of diagnostic devices impose compliance burdens on manufacturers and healthcare providers, affecting market entry barriers and operational costs. Furthermore, limited reimbursement coverage for diagnostic tests and the high cost of advanced diagnostic equipment pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and economic barriers requires collaboration between industry stakeholders and policymakers to promote access to accurate and affordable diagnostic solutions.

Market Opportunities:

The influenza diagnostics market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as remote monitoring and telemedicine platforms, enhances patient access to diagnostic services and improves treatment adherence and outcomes. Furthermore, the expanding application of diagnostics beyond influenza, including in the detection of other respiratory viruses and infections, broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective diagnostic solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic diagnostics landscape.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the influenza diagnostics market globally?
• Which diagnostic types and applications are driving influenza diagnosis across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the influenza diagnostics market?
• Who are the key players contributing to the influenza diagnostics market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global influenza diagnostics market?

Competitive Intelligence and Business Strategy:

Leading players in the global influenza diagnostics market, including Roche Diagnostics, Abbott Laboratories, and Quidel Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced diagnostic solutions, including molecular assays and point-of-care tests, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving diagnostics landscape.

Key Companies Profiled:

• Abbott Laboratories
• Endress+Hauser (Analytik Jena AG)
• Becton, Dickinson and Company
• Biocartis
• bioMérieux Inc
• Danaher Corporation (Cepheid)
• F. Hoffmann-La Roche Ltd
• GenMark Diagnostics, Inc.
• Luminex Corporation
• Meridian Bioscience, Inc
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Hologic

Key Segments Covered in Influenza Diagnostics Industry Research

Test:
• Molecular Diagnostic Test
• Traditional Diagnostic Test

Type of Flu:
• Type A Flu
• Type B Flu
• Type C Flu

End User:
• Hospitals
• Diagnostic Laboratories
• Research & Academic Institute
• Contract Research Organization (CRO’s)

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product USPs / Features
4.3. Strategic and Promotional Strategies
4.4. Key Regulations
4.5. Disease Epidemiology
4.6. PESTLE Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Market Outlook
5.1.3. Global Infectious Disease Diagnostics Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
5.2.2. Application Innovation in Influenza Diagnostics
5.2.3. Product Adoption Rate
5.2.4. Regulatory Impositions
5.2.5. Growing R&D Investments
5.2.6. Novel Diagnostic Product Development Activities
5.2.7. Awareness Campaigns for Influenza Diagnostics
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Test
6.1.2. By Type of Flu
6.1.3. By End User
6.2. 2024 Market Scenario
7. Global Influenza Diagnostics Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
7.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Test
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Test, 2019-2023
8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Test, 2024-2033
8.3.1. Molecular Diagnostics Tests
8.3.1.1. RT-PCR
8.3.1.2. LAMP
8.3.1.3. NASABA
8.3.2. Traditional Diagnostics Tests
8.3.2.1. Rapid Influenza Detection Kits
8.3.2.2. Serological Assays
8.3.2.3. Direct Fluorescent Antibody
8.3.2.4. Viral Culture
8.3.2.5. H1N1 Influenza A Virus Identification Kits
8.3.2.6. Immunoassay Kits
8.3.2.7. Immunofluorescence Antibody Assay
8.4. Market Attractiveness Analysis By Test
9. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, By Type of Flu
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Type of Flu, 2019-2023
9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Type of Flu, 2024-2033
9.3.1. Type A Flu
9.3.2. Type B Flu
9.3.3. Type C Flu
9.4. Market Attractiveness Analysis By Type of Flu
10. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
10.3.1. Hospitals
10.3.2. Diagnostic Laboratories
10.3.3. Research & Academic Institutes
10.3.4. Contract Research Organizations (CRO)
10.4. Market Attractiveness Analysis By End User
11. Global Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. South Asia
11.3.5. East Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
12.1. Introduction
12.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Test
12.3.3. By Type of Flu
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Test
12.4.3. By Type of Flu
12.4.4. By End User
12.5. Country Level Analysis & Forecast
12.5.1. U.S. Influenza Diagnostics Market Analysis
12.5.1.1. Introduction
12.5.1.2. Market Analysis and Forecast by Market Taxonomy
12.5.1.2.1. By Test
12.5.1.2.2. By Type of Flu
12.5.1.2.3. By End User
12.5.2. Canada Influenza Diagnostics Market Analysis
12.5.2.1. Introduction
12.5.2.2. Market Analysis and Forecast by Market Taxonomy
12.5.2.2.1. By Test
12.5.2.2.2. By Type of Flu
12.5.2.2.3. By End User
12.6. Market Trends
12.7. Key Market Participants – Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
12.9. Country Level Analysis & Forecast
13. Latin America Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Test
13.3.3. By Type of Flu
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Test
13.4.3. By Type of Flu
13.4.4. By End User
13.5. Country Level Analysis & Forecast
13.5.1. Brazil Influenza Diagnostics Market Analysis
13.5.1.1. Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Test
13.5.1.2.2. By Type of Flu
13.5.1.2.3. By End User
13.5.2. Mexico Influenza Diagnostics Market Analysis
13.5.2.1. Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Test
13.5.2.2.2. By Type of Flu
13.5.2.2.3. By End User
13.5.3. Argentina Influenza Diagnostics Market Analysis
13.5.3.1. Introduction
13.5.3.2. Market Analysis and Forecast by Market Taxonomy
13.5.3.2.1. By Test
13.5.3.2.2. By Type of Flu
13.5.3.2.3. By End User
13.6. Market Trends
13.7. Key Market Participants – Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
13.9. Country Level Analysis & Forecast
14. Europe Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Italy
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. Russia
14.3.1.7. BENELUX
14.3.1.8. Rest of Europe
14.3.2. By Test
14.3.3. By Type of Flu
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Test
14.4.3. By Type of Flu
14.4.4. By End User
14.5. Country Level Analysis & Forecast
14.5.1. Germany Influenza Diagnostics Market Analysis
14.5.1.1. Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Test
14.5.1.2.2. By Type of Flu
14.5.1.2.3. By End User
14.5.2. France Influenza Diagnostics Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Test
14.5.2.2.2. By Type of Flu
14.5.2.2.3. By End User
14.5.3. Italy Influenza Diagnostics Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Test
14.5.3.2.2. By Type of Flu
14.5.3.2.3. By End User
14.5.4. U.K. Influenza Diagnostics Market Analysis
14.5.4.1. Introduction
14.5.4.2. Market Analysis and Forecast by Market Taxonomy
14.5.4.2.1. By Test
14.5.4.2.2. By Type of Flu
14.5.4.2.3. By End User
14.5.5. Spain Influenza Diagnostics Market Analysis
14.5.5.1. Introduction
14.5.5.2. Market Analysis and Forecast by Market Taxonomy
14.5.5.2.1. By Test
14.5.5.2.2. By Type of Flu
14.5.5.2.3. By End User
14.5.6. Russia Influenza Diagnostics Market Analysis
14.5.6.1. Introduction
14.5.6.2. Market Analysis and Forecast by Market Taxonomy
14.5.6.2.1. By Test
14.5.6.2.2. By Type of Flu
14.5.6.2.3. By End User
14.5.7. BENELUX Influenza Diagnostics Market Analysis
14.5.7.1. Introduction
14.5.7.2. Market Analysis and Forecast by Market Taxonomy
14.5.7.2.1. By Test
14.5.7.2.2. By Type of Flu
14.5.7.2.3. By End User
14.6. Market Trends
14.7. Key Market Participants – Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
14.9. Country Level Analysis & Forecast
15. South Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Test
15.3.3. By Type of Flu
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Test
15.4.3. By Type of Flu
15.4.4. By End User
15.5. Country Level Analysis & Forecast
15.5.1. India Influenza Diagnostics Market Analysis
15.5.1.1. Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Test
15.5.1.2.2. By Type of Flu
15.5.1.2.3. By End User
15.5.2. Thailand Influenza Diagnostics Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Test
15.5.2.2.2. By Type of Flu
15.5.2.2.3. By End User
15.5.3. Indonesia Influenza Diagnostics Market Analysis
15.5.3.1. Introduction
15.5.3.2. Market Analysis and Forecast by Market Taxonomy
15.5.3.2.1. By Test
15.5.3.2.2. By Type of Flu
15.5.3.2.3. By End User
15.5.4. Malaysia Influenza Diagnostics Market Analysis
15.5.4.1. Introduction
15.5.4.2. Market Analysis and Forecast by Market Taxonomy
15.5.4.2.1. By Test
15.5.4.2.2. By Type of Flu
15.5.4.2.3. By End User
15.6. Market Trends
15.7. Key Market Participants – Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
15.9. Country Level Analysis & Forecast
16. East Asia Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Test
16.3.3. By Type of Flu
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Test
16.4.3. By Type of Flu
16.4.4. By End User
16.5. Country Level Analysis & Forecast
16.5.1. China Influenza Diagnostics Market Analysis
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Test
16.5.1.2.2. By Type of Flu
16.5.1.2.3. By End User
16.5.2. Japan Influenza Diagnostics Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Test
16.5.2.2.2. By Type of Flu
16.5.2.2.3. By End User
16.5.3. South Korea Influenza Diagnostics Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Test
16.5.3.2.2. By Type of Flu
16.5.3.2.3. By End User
16.6. Market Trends
16.7. Key Market Participants – Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
16.9. Country Level Analysis & Forecast
17. Oceania Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Test
17.3.3. By Type of Flu
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Test
17.4.3. By Type of Flu
17.4.4. By End User
17.5. Country Level Analysis & Forecast
17.5.1. Australia Influenza Diagnostics Market Analysis
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Test
17.5.1.2.2. By Type of Flu
17.5.1.2.3. By End User
17.5.2. New Zealand Influenza Diagnostics Market Analysis
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Test
17.5.2.2.2. By Type of Flu
17.5.2.2.3. By End User
17.6. Market Trends
17.7. Key Market Participants – Intensity Mapping
17.8. Drivers and Restraints - Impact Analysis
17.9. Country Level Analysis & Forecast
18. Middle East and Africa Influenza Diagnostics Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. North Africa
18.3.1.5. Rest of Middle East and Africa
18.3.2. By Test
18.3.3. By Type of Flu
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Test
18.4.3. By Type of Flu
18.4.4. By End User
18.5. Country Level Analysis & Forecast
18.5.1. GCC Countries Influenza Diagnostics Market Analysis
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Test
18.5.1.2.2. By Type of Flu
18.5.1.2.3. By End User
18.5.2. Turkey Influenza Diagnostics Market Analysis
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Test
18.5.2.2.2. By Type of Flu
18.5.2.2.3. By End User
18.5.3. South Africa Influenza Diagnostics Market Analysis
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Test
18.5.3.2.2. By Type of Flu
18.5.3.2.3. By End User
18.5.4. North Africa Influenza Diagnostics Market Analysis
18.5.4.1. Introduction
18.5.4.2. Market Analysis and Forecast by Market Taxonomy
18.5.4.2.1. By Test
18.5.4.2.2. By Type of Flu
18.5.4.2.3. By End User
18.6. Drivers and Restraints - Impact Analysis
18.7. Market Trends
18.8. Key Market Participants – Intensity Mapping
18.9. Country Level Analysis & Forecast
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Concentration
19.4. Market Presence Analysis
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Deep Dive
20.2.1. Abbott Laboratories
20.2.1.1. Overview
20.2.1.2. Product Portfolio
20.2.1.3. Key Financials
20.2.1.4. Sales Footprint
20.2.1.5. Strategy Overview
20.2.1.5.1. Marketing Strategy
20.2.1.5.2. Product Strategy
20.2.1.5.3. Channel Strategy
20.2.2. Endress+Hauser (Analytik Jena AG)
20.2.2.1. Overview
20.2.2.2. Product Portfolio
20.2.2.3. Key Financials
20.2.2.4. Sales Footprint
20.2.2.5. Strategy Overview
20.2.2.5.1. Marketing Strategy
20.2.2.5.2. Product Strategy
20.2.2.5.3. Channel Strategy
20.2.3. Becton, Dickinson and Company
20.2.3.1. Overview
20.2.3.2. Product Portfolio
20.2.3.3. Key Financials
20.2.3.4. Sales Footprint
20.2.3.5. Strategy Overview
20.2.3.5.1. Marketing Strategy
20.2.3.5.2. Product Strategy
20.2.3.5.3. Channel Strategy
20.2.4. Biocartis
20.2.4.1. Overview
20.2.4.2. Product Portfolio
20.2.4.3. Key Financials
20.2.4.4. Sales Footprint
20.2.4.5. Strategy Overview
20.2.4.5.1. Marketing Strategy
20.2.4.5.2. Product Strategy
20.2.4.5.3. Channel Strategy
20.2.5. bioMérieux Inc
20.2.5.1. Overview
20.2.5.2. Product Portfolio
20.2.5.3. Key Financials
20.2.5.4. Sales Footprint
20.2.5.5. Strategy Overview
20.2.5.5.1. Marketing Strategy
20.2.5.5.2. Product Strategy
20.2.5.5.3. Channel Strategy
20.2.6. Danaher Corporation (Cepheid)
20.2.6.1. Overview
20.2.6.2. Product Portfolio
20.2.6.3. Key Financials
20.2.6.4. Sales Footprint
20.2.6.5. Strategy Overview
20.2.6.5.1. Marketing Strategy
20.2.6.5.2. Product Strategy
20.2.6.5.3. Channel Strategy
20.2.7. F. Hoffmann-La Roche Ltd
20.2.7.1. Overview
20.2.7.2. Product Portfolio
20.2.7.3. Key Financials
20.2.7.4. Sales Footprint
20.2.7.5. Strategy Overview
20.2.7.5.1. Marketing Strategy
20.2.7.5.2. Product Strategy
20.2.7.5.3. Channel Strategy
20.2.8. GenMark Diagnostics, Inc.
20.2.8.1. Overview
20.2.8.2. Product Portfolio
20.2.8.3. Key Financials
20.2.8.4. Sales Footprint
20.2.8.5. Strategy Overview
20.2.8.5.1. Marketing Strategy
20.2.8.5.2. Product Strategy
20.2.8.5.3. Channel Strategy
20.2.9. Luminex Corporation
20.2.9.1. Overview
20.2.9.2. Product Portfolio
20.2.9.3. Key Financials
20.2.9.4. Sales Footprint
20.2.9.5. Strategy Overview
20.2.9.5.1. Marketing Strategy
20.2.9.5.2. Product Strategy
20.2.9.5.3. Channel Strategy
20.2.10. Meridian Bioscience, Inc
20.2.10.1. Overview
20.2.10.2. Product Portfolio
20.2.10.3. Key Financials
20.2.10.4. Sales Footprint
20.2.10.5. Strategy Overview
20.2.10.5.1. Marketing Strategy
20.2.10.5.2. Product Strategy
20.2.10.5.3. Channel Strategy
20.2.11. Quidel Corporation
20.2.11.1. Overview
20.2.11.2. Product Portfolio
20.2.11.3. Key Financials
20.2.11.4. Sales Footprint
20.2.11.5. Strategy Overview
20.2.11.5.1. Marketing Strategy
20.2.11.5.2. Product Strategy
20.2.11.5.3. Channel Strategy
20.2.12. Thermo Fisher Scientific Inc.
20.2.12.1. Overview
20.2.12.2. Product Portfolio
20.2.12.3. Key Financials
20.2.12.4. Sales Footprint
20.2.12.5. Strategy Overview
20.2.12.5.1. Marketing Strategy
20.2.12.5.2. Product Strategy
20.2.12.5.3. Channel Strategy
20.2.13. Hologic
20.2.13.1. Overview
20.2.13.2. Product Portfolio
20.2.13.3. Key Financials
20.2.13.4. Sales Footprint
20.2.13.5. Strategy Overview
20.2.13.5.1. Marketing Strategy
20.2.13.5.2. Product Strategy
20.2.13.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology